MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-WB-10-0010507
Diamond Drugs Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹38.26 Cr
▲ 2% YoY
Net profit · FY 2024
₹5.84 Cr
Net margin 15.3%
EBITDA · FY 2024
₹8.16 Cr
EBITDA margin 21.3%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.13 Cr
Issued & subscribed
Open charges
₹1.1 Cr
Satisfied ₹50 Lakh
Company age
22 yrs
Est. 2004
Employees · EPFO
84
Provident fund records
About Diamond Drugs Private Limited
Data last updated:
Diamond Drugs Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 December 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB2004PTC100709. Its GSTIN is 19AACCD1202G1Z8 (West Bengal).
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.13 Cr. It is led by directors including Soumyajit Sarkar and Mihir Sarkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 37 Sri Gopal Mullick Lane, Kolkata, West Bengal, India – 700037.
As per the financials filed for FY 2024, the company reported a revenue of ₹38.26 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹5.84 Cr (net margin 15.3%) and EBITDA of ₹8.16 Cr (EBITDA margin 21.3%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 15% over five years.
The company has about 84 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Diamond Drugs. As per MCA filings, the company has open charges of ₹1.1 Cr and satisfied charges of ₹50 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company.
Diamond Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0010507). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website diamonddrugs.co.in.
Company details
CIN U24239WB2004PTC100709
Registration Number 100709
Incorporation Date 15 December 2004
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-WB-10-0010507
Recognitions & Rankings of Diamond Drugs
Contact details
Diamond Drugs Private Limited's registered office is in Kolkata, West Bengal. Its website is diamonddrugs.co.in. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered Address37 Sri Gopal Mullick Lane, Kolkata, West Bengal, India – 700037
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Diamond Drugs Private Limited, buy the company report.
Comprehensive company report
Diamond Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Diamond Drugs operates one associated brand: Diamond Drugs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides pharmaceutical contract manufacturing, medicine sales, and formulations in India. | diamonddrugs.co.in |
Business activity
The main business activity of Diamond Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Diamond Drugs Private Limited, buy the company report.
Financials of Diamond Drugs Private Limited
FY 2025 filings availableDiamond Drugs Private Limited reported revenue of ₹38.26 Cr (up 2% YoY) for FY 2024.
Revenue · FY 2024
₹38.26 Cr ▲ 2%
Net profit · FY 2024
₹5.84 Cr margin 15.3%
EBITDA · FY 2024
₹8.16 Cr margin 21.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 29%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 70%
3 years · compounded
▲ 41%
5 years · compounded
▲ 25%
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 2% growth in the latest year. EBITDA rose 70% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.16 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.84 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.3% | ||||
| Net Profit Margin | 15.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Diamond Drugs Private Limited, buy the company report.
Board of directors of Diamond Drugs Private Limited
Diamond Drugs has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Soumyajit Sarkar | Director | 06 Sep 2024 | 2 Years 2 Months | Current |
| Mihir Sarkar Also directs: Sovana Developers Private Limited | Director | 15 Dec 2004 | 21 Years 10 Months | Current |
| Prabir Kumar Sarkar Also directs: Sovana Developers Private Limited | Director | 15 Dec 2004 | 21 Years 10 Months | Current |
Peer comparison
Diamond Drugs Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Revinto Life Science Private Limited | ₹38.71 Cr (FY 2024) | 44.0% | Karwar, Karnataka, India | |||
| Ultra Laboratories Private Limited | ₹38.64 Cr (FY 2024) | 36.0% | Bangalore, Karnataka, India | |||
| Medicamen Organics Limited. | ₹38.28 Cr (FY 2025) | 51.0% | New Delhi, Delhi, India | |||
| Diamond Drugs Private Limitedthis company | ₹38.26 Cr (FY 2024) | ₹5.84 Cr | 15.3% | 2.0% | 84 | Kolkata, West Bengal, India |
| Klar Sehen Pvt Ltd | ₹38.16 Cr (FY 2016) | 18.0% | Bidar, Karnataka, India | |||
| Tulip Lab Private Limited | ₹38.12 Cr (FY 2023) | -78.0% | Mumbai, Maharashtra, India | |||
| Biomax Biotechnics Private Limited | ₹38.1 Cr (FY 2025) | 9.0% | Chandigarh, India |
To see the full peer comparison of Diamond Drugs Private Limited, buy the company report.
Auditor
Diamond Drugs Private Limited is audited by P K KHARA & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P K KHARA & ASSOCIATES | FY 2021 | 314095E |
Shareholding
The shareholding of Diamond Drugs Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Diamond Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.1 Cr
Satisfied charges
₹50 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Mar 2015 | 10563720 | Yes Bank Limited | ₹1.1 Cr | Open | |
| 03 Dec 2005 | 90370991 | State Bank of India | ₹50 Lakh | Satisfied |
To see the full charge records of Diamond Drugs Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Diamond Drugs Private Limited has 2 court cases on record: 2 filed by Diamond Drugs. All cases are disposed.
Total cases
2
Filed by the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
| High courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Calcutta High Court | Court case (CO) | Filed by the company against The Secretary, Health and Family Welfare Department & Ors | Disposed |
| District court, Hooghly, West Bengal | Civil suit | Filed by the company against an individual | Disposed |
To see the full case history of Diamond Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Diamond Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Diamond Drugs Private Limited has a workforce of 84 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
84
Active EPFO establishments
1
GST
Diamond Drugs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AACCD1202G1Z8 | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Diamond Drugs Private Limited, buy the company report.
Recent activity
Diamond Drugs Private Limited has 5 board changes on record since 2004: 3 appointments and 2 cessations. The latest: Soumyajit Sarkar ceased to be Additional Director on 29 Sep 2024.
AGM
Diamond Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Diamond Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Ceased
Soumyajit Sarkar ceased to be Additional Director.
Appointed
Soumyajit Sarkar was appointed as Director.
Ceased
Silpi Sarkar ceased to be Director.
Charges
A charge with Yes Bank Limited of Rs. 1.10 Cr registered on 28 Mar 2015 with Charge ID 10563720 was modified on 27 Jul 2018.
Charges
A charge registered on 03 Dec 2005 via Charge ID 90370991 with State Bank Of India was fully satisfied on 07 Apr 2015.
Charges
A charge with Yes Bank Limited amounted to Rs. 1.10 Cr with Charge ID 10563720 was registered on 28 Mar 2015.
Charges
A charge with State Bank Of India amounted to Rs. 0.50 Cr with Charge ID 90370991 was registered on 03 Dec 2005.
Appointed
Mihir Sarkar was appointed as Director.
Appointed
Prabir Kumar Sarkar was appointed as Director.
Incorporation
15 Dec 2004
Diamond Drugs Private Limited was registered on 15 Dec 2004 with Roc Kolkata & aged 21 years 10 months as per MCA records.
Frequently asked questions
Diamond Drugs is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 December 2004 (22+ years old) and is registered under CIN U24239WB2004PTC100709.
Diamond Drugs has 3 current directors:
- Soumyajit Sarkar - Director
- Mihir Sarkar - Director
- Prabir Kumar Sarkar - Director
The latest financial statements of Diamond Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Diamond Drugs is 19AACCD1202G1Z8, registered in West Bengal.
The CIN (Corporate Identification Number) of Diamond Drugs is U24239WB2004PTC100709. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Diamond Drugs has 2 court cases on record: 2 filed by the company. Most are in the district courts.
Diamond Drugs was incorporated on 15 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Diamond Drugs by revenue are Revinto Life Science Private Limited, Ultra Laboratories Private Limited, Medicamen Organics Limited, Klar Sehen Pvt Ltd, Tulip Lab Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Soumyajit Sarkar ceased to be Additional Director on 29 Sep 2024. Soumyajit Sarkar was appointed as Director on 06 Sep 2024. Silpi Sarkar ceased to be Director on 30 Aug 2024. Diamond Drugs has 5 board changes on record in total.
Yes, Diamond Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-WB-10-0010507).
Diamond Drugs can be reached through the website diamonddrugs.co.in. Its registered office is in Kolkata, West Bengal, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages